Actively Recruiting
Real-World Study Comparing Conservative and Endovascular Treatments for Spontaneous Superior Mesenteric Artery Dissection
Led by Xiangya Hospital of Central South University · Updated on 2022-04-22
200
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
X
Xiangya Hospital of Central South University
Lead Sponsor
T
The First Medical Center of Chinese PLA General Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying Spontaneous Isolated Superior Mesenteric Artery Dissection SISMAD, a condition increasingly diagnosed but with limited evidence guiding treatment. This observational study compares the effects of conservative treatment versus endovascular treatment to understand which approach better helps patients with this condition. The study is sponsored by Xiangya Hospital of Central South University and aims to provide real-world evidence to improve clinical decisions for SISMAD. Participants receive either endovascular treatments or conservative care. Conservative treatment includes managing blood pressure, bowel rest, antithrombotic therapy, nutritional support, and pain control. The study observes these treatment groups over time to assess outcomes without altering usual care. There is no randomization or blinding since this is an observational study. Participants will be followed for up to five years with regular monitoring of symptom relief and survival. Researchers will also track reintervention needs, recurrence, disease complications, and artery remodeling. Patients will undergo clinical evaluations and imaging to assess their conditions progress. The study involves long-term observation to gather comprehensive data on treatment effects and safety.
CONDITIONS
Brief Title
Comparison of Conservative and Endovascular Treatment for Spontaneously Isolated Superior Mesenteric Artery Dissection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 and above
- Diagnosed with isolated superior mesenteric artery dissection confirmed by CTA with clear symptoms or history
- Signed informed consent and willing to receive treatments
You will not qualify if you...
- Severe symptoms requiring exploratory laparotomy
- Having aortic dissection, iliac artery dissection, or autoimmune vasculitis
- Mental illness preventing cooperation
- Allergy to contrast agents or contraindications to conservative treatment drugs
- Pregnancy, breastfeeding, or recent plans to give birth
- Participation in other clinical trials
- Deemed unsuitable for participation by investigators
Research Team
W
Wang WEI, Ph.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here